e _ e_
s _ s_
a n an
e r er
t h th
i n in
d _ d_
_ c _c
a t at
o n on
e n en
r e re
o r or
, _ ,_
a l al
an c anc
y _ y_
anc er ancer
a r ar
th e_ the_
o f of
s t st
e d_ ed_
o m om
. _ ._
i on ion
_c ancer _cancer
i c ic
t _ t_
o _ o_
an d_ and_
e s_ es_
in g ing
of _ of_
e l el
in _ in_
t o_ to_
d i di
r o ro
i s_ is_
e s es
ing _ ing_
or _ or_
a s as
at ion ation
a _ a_
s u su
i t it
c t ct
en t ent
u s us
i v iv
i s is
e_ c e_c
al _ al_
d e de
_cancer _ _cancer_
th er ther
e t et
o u ou
a s_ as_
i l il
a g ag
al l all
an _ an_
at _ at_
p ro pro
i g ig
h _ h_
ar e_ are_
l e le
i m im
n o no
o p op
a p ap
th _ th_
l o lo
i r ir
en _ en_
T h Th
e m em
a m am
d u du
l u lu
er _ er_
g en gen
w i wi
s ,_ s,_
in c inc
f e fe
ation _ ation_
r a ra
a us aus
p re pre
l e_ le_
e x ex
el l ell
a st ast
s e se
w h wh
m a ma
u l ul
a b ab
u r ur
_ of_ _of_
ic _ ic_
u m um
r om rom
th at_ that_
._ Th ._Th
a v av
p e pe
en t_ ent_
a c ac
t re tre
o l ol
m o mo
o s os
in_ the_ in_the_
ancer _ ancer_
l y_ ly_
o c oc
f or_ for_
r is ris
ris k risk
or m orm
wi th_ with_
y p yp
o ther other
b y_ by_
tre at treat
iv e_ ive_
su r sur
on _ on_
u t ut
i d id
e st est
m ent ment
_c ell _cell
n _ n_
ion _ ion_
ar c arc
_c h _ch
fe ct fect
i f if
e_ of_ e_of_
e f ef
om m omm
a d ad
s_ and_ s_and_
e d ed
ma y_ may_
h av hav
t o to
v el vel
f rom from
b e_ be_
all y_ ally_
t er ter
a ct act
re as reas
s ._ s._
i b ib
m p mp
_c aus _caus
b e be
q u qu
s c sc
t um tum
u n un
A _ A_
e v ev
s y sy
hav e_ have_
t yp typ
y ,_ y,_
h e he
at ed_ ated_
c h_ ch_
e_ the_ e_the_
no t_ not_
ig h igh
e_ to_ e_to_
from _ from_
s_ of_ s_of_
of _cancer of_cancer
p at pat
il l ill
inc lu inclu
en c enc
p ar par
s_ are_ s_are_
t r tr
du c duc
b re bre
_ and_ _and_
re s res
of _cancer_ of_cancer_
inc reas increas
om e_ ome_
su ch_ such_
w or wor
h o ho
ther ap therap
mo st most
i z iz
es ,_ es,_
ic al_ ical_
._Th e_ ._The_
bre ast breast
no s nos
p o po
ra di radi
c ur cur
o d od
inclu d includ
_c on _con
de vel devel
devel op develop
e ,_ e,_
_cancer ,_ _cancer,_
ou n oun
m or mor
such_ as_ such_as_
o gen ogen
di se dise
dise as diseas
p l pl
de a dea
ed_ by_ ed_by_
v ir vir
c aus caus
n e ne
p a pa
op le_ ople_
it y_ ity_
m ent_ ment_
m ut mut
ig n ign
i t_ it_
._ I ._I
pre s pres
th an_ than_
i st ist
ar y_ ary_
ir _ ir_
tum or tumor
D N DN
arc in arcin
an g ang
treat ment treatment
m et met
e_c ancer e_cancer
0 0 00
s . s.
p r pr
o lo olo
ar _ ar_
o v ov
n g ng
l i li
p h ph
f orm form
wh ic whic
ac c acc
) _ )_
re ct rect
th at that
e_c ancer_ e_cancer_
m e me
u g ug
om a_ oma_
oc cur occur
ation s_ ations_
th e the
t ion tion
l y ly
an y_ any_
t est test
i es_ ies_
di ag diag
v i vi
e p ep
h as_ has_
DN A_ DNA_
on g ong
ed_ c ed_c
al s als
ou t_ out_
ou s_ ous_
risk _ risk_
re c rec
pat i pati
) ,_ ),_
v ent vent
ed_ to_ ed_to_
g ro gro
the_ b the_b
w e we
e ._ e._
ther _ ther_
f act fact
et ic_ etic_
en d end
y s ys
the_ c the_c
par t part
an t ant
% _ %_
' s_ 's_
p er per
re qu requ
re en reen
diag nos diagnos
_c omm _comm
at es_ ates_
e_ and_ e_and_
o d_ od_
p le ple
u p up
om a oma
as s ass
pati ent patient
2 0 20
pe ople_ people_
s_ to_ s_to_
ast as astas
c h ch
treat ment_ treatment_
el i eli
in v inv
other _ other_
_c an_ _can_
b u bu
re d_ red_
other ap otherap
at iv ativ
sur v surv
f f ff
ex am exam
lo w low
whic h_ which_
sy mp symp
symp t sympt
sympt om symptom
es e_ ese_
dea th death
or s_ ors_
pe c pec
sc reen screen
Th e_ The_
radi ation_ radiation_
d r dr
lu ng lung
k in kin
mor e_ more_
w as_ was_
_cell s_ _cells_
pro g prog
ef fect effect
_caus e_ _cause_
._ A ._A
al ter alter
n orm norm
a d_ ad_
typ es_ types_
a f af
o b ob
be en_ been_
t e te
risk _of_ risk_of_
g er ger
em otherap emotherap
er e_ ere_
wi th with
pres s press
ou r our
gro w grow
i al_ ial_
als o_ also_
ar e_c are_c
t a ta
el y_ ely_
bu t_ but_
m ed med
s_ c s_c
th ro thro
f or for
ic ul icul
ab out_ about_
occur _ occur_
d er der
._Th is_ ._This_
re l rel
h igh high
re pa repa
_cell _ _cell_
st _ st_
wor l worl
es s ess
du e_to_ due_to_
re duc reduc
._ C ._C
surv iv surviv
all _ all_
de c dec
st at stat
e ar ear
oun d_ ound_
n on non
s ome_ some_
on e_ one_
o t ot
_c arcin _carcin
_c om _com
s ign sign
y l yl
ic i ici
_ to_ _to_
ho w how
in h inh
and_ c and_c
thro ug throug
p or por
an t_ ant_
most _comm most_comm
m al mal
is su issu
met astas metastas
_cancer_ is_ _cancer_is_
er ,_ er,_
an s ans
b et bet
at ive_ ative_
li k lik
t ra tra
s ib sib
includ e_ include_
o w ow
in fect infect
ly mp lymp
m u mu
s_ ( s_(
it ed_ ited_
screen ing_ screening_
he al heal
al _cancer al_cancer
at e_ ate_
ag e_ age_
._ F ._F
1 9 19
, _c ,_c
b l bl
b lo blo
en d_ end_
l iv liv
pr im prim
l if lif
mut ation mutation
le vel level
g et get
oc i oci
ing_ the_ ing_the_
throug h_ through_
er v erv
_ m _m
e . e.
em i emi
non - non-
o st ost
ion _of_ ion_of_
t issu tissu
ab le_ able_
olo g olog
u re ure
tr ans trans
l in lin
the ir_ their_
d es des
s h sh
pro v prov
pre vent prevent
repa ir_ repair_
ation ,_ ation,_
s pec spec
worl d world
gen es_ genes_
m any_ many_
ang es_ anges_
C ancer Cancer
ic ally_ ically_
t en_ ten_
sur ger surger
st em stem
all i alli
ativ e_c ative_c
._I n_ ._In_
c on con
k _ k_
st r str
di ff diff
ell _ ell_
it s_ its_
exam ple example
of_ the_ of_the_
s_ in_ s_in_
most _ most_
in to_ into_
g n gn
0 _ 0_
st u stu
er r err
di t dit
t er_ ter_
rec omm recomm
% _of_ %_of_
vir on viron
viron ment vironment
,_ and_ ,_and_
s om som
v er ver
olo rect olorect
_ch emotherap _chemotherap
alli ative_c alliative_c
may_ be_ may_be_
os e_ ose_
I n_ In_
w _ w_
w ere_ were_
s kin skin
l d_ ld_
le u leu
leu k leuk
leuk emi leukemi
no t not
wh o_ who_
p on pon
all ed_ alled_
di s dis
us ed_ used_
su p sup
high er_ higher_
b eli beli
our c ourc
p os pos
C ancer_ Cancer_
grow th_ growth_
._ P ._P
symptom s_ symptoms_
ou g oug
igh t_ ight_
il e_ ile_
es ._ es._
c t_ ct_
ex po expo
ap pro appro
ass oci associ
an d and
pro c proc
h ar har
es s_ ess_
er g erg
U n Un
S t St
ill ion_ illion_
c ancer cancer
ou ld_ ould_
_cancer s_ _cancers_
the_ s the_s
tum or_ tumor_
ill _ ill_
di v div
res s ress
ul t ult
k ing_ king_
in e_ ine_
S ome_ Some_
is_ c is_c
pre gn pregn
bet we betwe
du ct duct
ov er over
ic al ical
di sc disc
d am dam
DNA_ repair_ DNA_repair_
sib le_ sible_
lo s los
f r fr
fact ors_ factors_
en vironment environment
s how show
per s pers
s mo smo
at ing_ ating_
i al ial
of ten_ often_
b in bin
y_ and_ y_and_
._ M ._M
sy stem system
part icul particul
20 1 201
_c as _cas
on ly_ only_
ph ys phys
su b sub
re g reg
pro duc produc
s_ that_ s_that_
re su resu
resu l resul
lo c loc
f requ frequ
s id sid
example ,_ example,_
ol on olon
h yp hyp
prim ary_ primary_
a re are
f er fer
is_ not_ is_not_
dea th_ death_
gen er gener
increas ed_ increased_
ig en igen
pro te prote
: _ :_
ex press express
ur e_ ure_
ol v olv
norm al normal
with_ the_ with_the_
the_b od the_bod
e_c on e_con
ing ,_ ing,_
l ong long
th ese_ these_
h um hum
v e ve
es_ in_ es_in_
e t_ et_
er ta erta
expo sur exposur
iz ing_ izing_
p ol pol
vir us virus
he pat hepat
de f def
l y,_ ly,_
ar ly_ arly_
gen etic_ genetic_
med ical_ medical_
f ir fir
heal th health
ad v adv
surviv al_ survival_
diseas e_ disease_
y . y.
y ear year
ex c exc
i p ip
w ill_ will_
blo od_ blood_
ap pe appe
as_ the_ as_the_
._F or_ ._For_
_c an _can
i d_ id_
m at mat
ev er,_ ever,_
es_ and_ es_and_
dec reas decreas
i ally_ ially_
betwe en_ between_
a_ s a_s
th is_ this_
f ound_ found_
ar i ari
c ancer_ cancer_
therap y_ therapy_
e_of_ the_ e_of_the_
" _ "_
recomm end recommend
ed_ that_ ed_that_
re se rese
rese arc researc
inv olv involv
a in ain
in d ind
acc o_ acco_
i a ia
t ro tro
u s_ us_
associ ated_ associated_
d o do
typ ically_ typically_
igh t ight
breast _cancer_ breast_cancer_
ation_ of_ ation_of_
alliative_c are_ alliative_care_
e_c h e_ch
on_ the_ on_the_
is ,_ is,_
in_the_ develop in_the_develop
ov er_ over_
most_comm on_ most_common_
pro stat prostat
olorect al olorectal
breast _cancer breast_cancer
m el mel
mel an melan
lymp h lymph
if ic ific
li fe life
r ates_ rates_
prog ress progress
to _cancer_ to_cancer_
e ople_ eople_
id e_ ide_
s,_ such_as_ s,_such_as_
includ ing_ including_
h orm horm
b o bo
or g org
m is mis
st anc stanc
w om wom
beli ev believ
R a Ra
Ra di Radi
s ourc sourc
wh en_ when_
be caus becaus
ter m term
p rom prom
pl ic plic
am e_ ame_
du r dur
i de ide
diagnos is_ diagnosis_
rom os romos
romos om romosom
ab il abil
igen etic_ igenetic_
me th meth
oma ,_ oma,_
is_ a_ is_a_
t ent tent
fe ct_ fect_
ab l abl
ag ent agent
it is_ itis_
._ H ._H
,_ but_ ,_but_
m un mun
f ul ful
requ i requi
1 0 10
_c erta _certa
ag ing_ aging_
b i bi
th ose_ those_
_ch il _chil
Un ited_ United_
United_ St United_St
es . es.
_m illion_ _million_
f _ f_
melan oma_ melanoma_
ong _ ong_
s_ with_ s_with_
l ar lar
form _ form_
_ or_ _or_
as s_ ass_
mal ign malign
k no kno
kno w know
; _ ;_
u su usu
res pon respon
l am lam
le ad lead
rel ated_ related_
re at reat
in ter inter
c ul cul
omm on_ ommon_
M et Met
tre at_ treat_
fact or factor
to_ be_ to_be_
ou t out
se qu sequ
pregn anc pregnanc
ation al_ ational_
ig h_ igh_
._ O ._O
c r cr
stu di studi
at t att
c ogen cogen
prote in protein
inh ib inhib
inhib it inhibit
s el sel
en erg energ
energ y_ energy_
p en pen
ple ment plement
f ac fac
b en ben
b le ble
W h Wh
ind ic indic
c o co
exposur e_to_ exposure_to_
ion izing_ ionizing_
lu t lut
._Th ese_ ._These_
i ous_ ious_
hepat itis_ hepatitis_
E p Ep
ar r arr
im mun immun
have_ been_ have_been_
c c cc
et ic etic
de fect defect
smo k smok
l im lim
y_ of_ y_of_
therap y,_ therapy,_
y , y,
t ar tar
therap y therapy
or e_ ore_
d el del
adv anc advanc
por t port
of_cancer_ and_ of_cancer_and_
un d und
5 _ 5_
e - e-
es_ of_ es_of_
ac h_ ach_
w ould_ would_
b ra bra
, 00 ,00
in it init
c om com
s e_ se_
ib ut ibut
s_ or_ s_or_
ent ly_ ently_
in di indi
resul t result
af fect affect
th oug thoug
vent ion vention
an e ane
b od bod
at ic_ atic_
or ig orig
metastas iz metastasiz
st ag stag
lif er lifer
ogen es ogenes
if _ if_
ma j maj
mut ations_ mutations_
sequ enc sequenc
dr ug drug
e_the_ risk_of_ e_the_risk_of_
med ic medic
D i Di
diff er differ
id enc idenc
h igh_ high_
- in -in
has_ been_ has_been_
ed_ as_ ed_as_
_con c _conc
er e ere
mut ation_ mutation_
_cancer_ ( _cancer_(
it_ is_ it_is_
d ing_ ding_
the y_ they_
) _and_ )_and_
ar is aris
prom ot promot
level s_of_ levels_of_
af ter_ after_
ct ive_ ctive_
express ion_of_ expression_of_
._ A_ ._A_
dam ag damag
su ff suff
vi e vie
ep igenetic_ epigenetic_
h el hel
al ity_ ality_
_chemotherap y_ _chemotherapy_
po tent potent
pre ad_ pread_
s,_ which_ s,_which_
d o_ do_
types_ of_cancer types_of_cancer
to b tob
co h coh
coh ol cohol
infect ion infection
environment al_ environmental_
I n In
act er acter
at ely_ ately_
1 6 16
s arc sarc
immun e_ immune_
f ol fol
ag ain again
pers on person
ast _ ast_
._ T ._T
inh er inher
._ E ._E
tar get target
patient 's_ patient's_
er s_ ers_
t_ of_ t_of_
_cas es_ _cases_
pe op peop
ther e_ there_
ac h ach
the_ most_common_ the_most_common_
ed_ in_ ed_in_
ar ound_ around_
%_ of %_of
leukemi a_ leukemia_
,_ wh ,_wh
oun tr ountr
U S US
1 . 1.
from_ the_ from_the_
im il imil
s ._The_ s._The_
m ass_ mass_
i x ix
inclu de include
include : include:
l ess_ less_
know n_ known_
on _cancer on_cancer
vi du vidu
us ,_ us,_
in al_ inal_
re f ref
horm on hormon
sy n syn
hyp er hyper
whic h which
ation_ and_ ation_and_
inv as invas
E x Ex
t end_ tend_
tend_ to_ tend_to_
trans mis transmis
C h Ch
sub stanc substanc
re e_ ree_
es_ the_ es_the_
es pec espec
Cancer s_ Cancers_
pro duct product
t w tw
ra ther_ rather_
o x ox
pl a pla
- c -c
pro lifer prolifer
Radi ation_ Radiation_
skin _cancer skin_cancer
._ S ._S
_com bin _combin
an im anim
b ir bir
t im tim
us ed_to_ used_to_
des cr descr
on _cancer_ on_cancer_
il y_ ily_
lik e_ like_
m ic mic
k e_ ke_
s it sit
on cogen oncogen
is m ism
_ch romosom _chromosom
